Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Dec 2024 for Knight Therapeutics Inc., €1,678.
Filing timeline
BuySaleJanice Jean Murray
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Janice Jean Murray: trading record in brief
Janice Jean Murray discloses dealings in Knight Therapeutics Inc. to SEDI. The record holds 7 filings, for trades running from 25 June 2020 to 15 December 2024.
On the market, this insider has only ever bought: 2 purchases, €15k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants.
The record was last updated on 18 December 2024 with a share grant (€1,678) in Knight Therapeutics Inc. The latest purchase dates back some time: it was published 1,654 days ago, on 17 April 2022. Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Janice Jean Murray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
477 shares@ CA$5.245.2% of flowCommon SharesTSXSEDI:4420069
495 shares@ CA$5.047.3% of flowCommon SharesTSXSEDI:4098186
1,883 shares@ CA$5.3129.7% of flowCommon SharesTSXSEDI:4064279
1,900 shares@ CA$5.3024.1% of flowCommon SharesTSXSEDI:3933082
Canonical exit: 12 Jul 2022 (T+90)
1,915 shares@ CA$5.22100.0% of flowCommon SharesTSXSEDI:3764657
Common SharesTSXSEDI:3662327
2,300 shares@ CA$5.2753.6% of flowCommon SharesTSXSEDI:3662341
Canonical exit: 13 Apr 2021 (T+90)
7 of 7 declarations
